Now, in its second year, the accelerator program is focused exclusively on supporting, mentoring, and advancing life science tools startup companies at all stages of fundraising. At this year's capstone event, six finalists -- selected from over 160 applicants -- will compete for a $250,000 non-dilutive grand prize and the title of 2022 BioTools Innovator.
Kathryn Zavala, PhD, managing director of BioTools Innovator, told the Science Advisory Board that the six finalists are "downstream from the early stages" and are "fully formed companies" that are looking to accelerate. Many of the companies are "platform technologies" in the areas of bioprocessing, proteomics, and single-cell technologies with applications in drug delivery and development, according to Zavala.
This year's six finalists include:
At the capstone event, the six finalists will each have seven minutes to pitch their technology and answer questions from a panel of judges. Ultimately, the audience will vote in real-time and decide the winner. Visit the BioTools Innovator registration webpage to register to attend the October 13 capstone event.
Watch the video below to learn more.